Over the current book year the total revenu from the company based in Cambridge will be 19.08 billion USD (consensus estimates). This is slightly more than 2021's revenue of 18.47 billion USD.
The analysts expect for 2022 a net profit of 8.86 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 21.51 USD. Based on this the price/earnings-ratio is 8.35.
For this year analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies equals an attractive 3.55 percent.
Moderna Inc 's market value equals around 71.62 billion . -35
At 15.40 the stock trades 1.09 percent lower at 179.59 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.